These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9715201)

  • 21. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
    Wordell CJ; Hauptman SP
    Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis.
    Fox BC; Sollinger HW; Belzer FO; Maki DG
    Am J Med; 1990 Sep; 89(3):255-74. PubMed ID: 2118307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of adverse drug reactions between high- and standard-dose trimethoprim-sulfamethoxazole in the ambulatory setting.
    Nguyen AT; Gentry CA; Furrh RZ
    Curr Drug Saf; 2013 Apr; 8(2):114-9. PubMed ID: 23713542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
    Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
    Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes.
    Rello J; Torres A; Ricart M; Valles J; Gonzalez J; Artigas A; Rodriguez-Roisin R
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1545-9. PubMed ID: 7952612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uncomplicated urinary tract infections: lomefloxacin versus trimethoprim/sulphamethoxazole.
    Guibert J; Capron MH
    J Int Med Res; 1992 Nov; 20(6):467-74. PubMed ID: 1337525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicenter study of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated acute pyelonephritis.
    Mouton Y; Ajana F; Chidiac C; Capron MH; Home P; Masquelier AM
    Am J Med; 1992 Apr; 92(4A):87S-90S. PubMed ID: 1316078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the safety and efficacy of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infections: results from a multicenter study.
    Andrade-Villanueva J; Flores-Gaxiola A; Lopez-Guillen P; Aguirre-Avalos G; Morfin-Otero R; Rodriguez-Noriega E
    Am J Med; 1992 Apr; 92(4A):71S-74S. PubMed ID: 1316074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.
    Martin JN; Rose DA; Hadley WK; Perdreau-Remington F; Lam PK; Gerberding JL
    J Infect Dis; 1999 Dec; 180(6):1809-18. PubMed ID: 10558935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection.
    Markowitz N; Quinn EL; Saravolatz LD
    Ann Intern Med; 1992 Sep; 117(5):390-8. PubMed ID: 1503330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significant reduction in methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia associated with the institution of a prevention protocol.
    Rumbak MJ; Cancio MR
    Crit Care Med; 1995 Jul; 23(7):1200-3. PubMed ID: 7600827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Switch to atovaquone and subsequent re-challenge with trimethoprim-sulfamethoxazole for Pneumocystis prophylaxis in a kidney transplant population.
    McLaughlin MM; Galal A; Richardson CL; Sutton SH; Barr VO; Patel N; Mitchell P; Stosor V
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28833985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
    Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
    Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections.
    Miller LG; Daum RS; Creech CB; Young D; Downing MD; Eells SJ; Pettibone S; Hoagland RJ; Chambers HF;
    N Engl J Med; 2015 Mar; 372(12):1093-103. PubMed ID: 25785967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management and epidemiologic analyses of an outbreak due to methicillin-resistant Staphylococcus aureus.
    Goetz MB; Mulligan ME; Kwok R; O'Brien H; Caballes C; Garcia JP
    Am J Med; 1992 Jun; 92(6):607-14. PubMed ID: 1605142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral rifampin and trimethoprim/sulfamethoxazole therapy in asymptomatic carriers of methicillin-resistant Staphylococcus aureus infections.
    Ellison RT; Judson FN; Peterson LC; Cohn DL; Ehret JM
    West J Med; 1984 May; 140(5):735-40. PubMed ID: 6610253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial.
    Pizzo PA; Robichaud KJ; Edwards BK; Schumaker C; Kramer BS; Johnson A
    J Pediatr; 1983 Jan; 102(1):125-33. PubMed ID: 6336781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High daily doses of trimethoprim/sulfamethoxazole are an independent risk factor for adverse reactions in patients with pneumocystis pneumonia and AIDS.
    Chang HM; Tsai HC; Lee SS; Kunin C; Lin PC; Wann SR; Chen YS
    J Chin Med Assoc; 2016 Jun; 79(6):314-9. PubMed ID: 27025225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation.
    Prasad GVR; Beckley J; Mathur M; Gunasekaran M; Nash MM; Rapi L; Huang M; Zaltzman JS
    BMC Infect Dis; 2019 Apr; 19(1):311. PubMed ID: 30953458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A dose-escalation regimen of trimethoprim-sulfamethoxazole is tolerable for prophylaxis against Pneumocystis jiroveci pneumonia in rheumatic diseases.
    Takenaka K; Komiya Y; Ota M; Yamazaki H; Nagasaka K
    Mod Rheumatol; 2013 Jul; 23(4):752-8. PubMed ID: 22907597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.